About Belluscura
Belluscura is a publicly listed company based in Dallas (United States) founded in 2015. Belluscura has raised $6.38 million across 8 funding rounds from investors including Tekcapital. Belluscura has completed 2 acquisitions, including Nanotether and TMT Acquisition. Belluscura offers products and services including X-PLOR, DISCOV-R, and Accessories. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its legal entity is BELLUSCURA, LLC. Its competitors include ALung, Securisyn and Synapse Biomedical; 3 of its 3 listed competitors have raised funding.
Company details
Provider of medical devices for laparoscopic procedures. It offers Passport a single-use, and disposable trocar (laparoscopic access device); Slyde- patient evacuation equipment ; Snap II - Level of Consciousness (LoC) device during general anesthesia, etc. The company aims to provide proprietary medical devices at affordable prices across a wide variety of treatment and diagnostic disciplines.
- Total Equity Funding$6.38M (USD)
in 8 rounds
- Latest Funding Round$4.98M (USD), Post-IPO
Feb 2025
- Investors
- Investments & AcquisitionsNanotether
& 1 more
Products & Services of Belluscura
Belluscura offers a comprehensive portfolio of products and services, including X-PLOR, DISCOV-R, and Accessories.
Lightweight device for on-the-go supplemental oxygen therapy.
Compact unit with high oxygen output for active patients.
Items for maintaining and enhancing oxygen concentrator use.
Apps and channels of Belluscura
its YouTube channel Belluscura has 123 subscribers and 22 videos.
Videos from Belluscura
The most watched videos on Belluscura's YouTube channel, Belluscura (123 subscribers). Click a video to play it here.
More on Belluscura.
Funding Insights of Belluscura
Belluscura has successfully raised a total of $6.38M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4.98 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.38M
- Total Rounds 8
- Last Round Post-IPO — $4.98M
- First Round $500,000
(Jun 2016)
- Investors Count 1
All 8 funding rounds of Belluscura with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | $4.98M | Post-IPO | – | – | – |
| Jun 2019 | $954,495 | Series A | – | – | – |
| Apr 2019 | $649,294 | Series A | – | Tekcapital | – |
| May 2018 | $603,000 | Series A | – | – | – |
| Feb 2018 | $1.3M | Series A | – | – | – |
| May 2017 | $1.7M | Series A | – | – | |
| Oct 2016 | $675,000 | Series A | – | – | – |
| Jun 2016 | $500,000 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Belluscura
Belluscura has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Tekcapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Technologies from global universities are acquired and commercialized. | 2012 | tekcapital.com | Miami, United States |
Investor details for Belluscura
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Belluscura
14 people are tracked at Belluscura (8 in leadership, 4 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
Keith Cook | VP, Operations | Leadership |
Sarah C. | Director Of Product Development | Leadership |
Anthony Dyer | CFO | Leadership |
Robert Rauker | CEO | Leadership |
Bob Fary | Senior VP Of Global Sales | Leadership |
Bob Rauker | CEO | Leadership |
Mark Vines | Director Of Operations | Leadership |
Denise Warner- Knight | Director Of Customer Service | Leadership |
Richard Piper | Non-Executive Director | Board & advisors |
Patrick Strollo | Non-Executive Director | Board & advisors |
David Poutney | Non-Executive Director | Board & advisors |
Adam Reynolds | Non-Executive Chairman | Board & advisors |
Brian Brown | SVP of Engineering | Team |
Tony Dyer | Company Secretary | Team |
Complete people profiles for Belluscura
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Belluscura
Belluscura has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Nanotether and TMT Acquisition.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of wireless telecommunication infrastructures | tmtacquisition.com | London, United Kingdom | 2021 | Oct 2023 | •••• | |
Technology for accelerating drug candidates via DNA tethers is provided. | nanotether.co.uk | Cardiff, United Kingdom | 2012 | Apr 2017 | •••• |
Complete acquisition details for Belluscura
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Belluscura
6 dated milestones of Belluscura across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Belluscura is founded.
- Funding First funding round of $500K.
- Acquisition Acquires Nanotether.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires TMT Acquisition.
- Funding Latest funding round, Post-IPO, of $5.0M.
Competitors of Belluscura
Belluscura has 3 listed competitors in our database, 3 of them funded. They include ALung, Securisyn and Synapse Biomedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alung.com | 1997 | Pittsburgh, United States | $130.87M | 27 | Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation. | |
| securisyn.com | 2011 | Denver, United States | $16.79M | Endotracheal tube stabilization systems for ventilated patients are developed. | ||
| synapsebiomedical.com | 2002 | Cleveland, United States | $1.76M | Neurostimulation device to treat spinal cord injury and ALS |
Detailed competitors of Belluscura
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Belluscura
The website of Belluscura (belluscura.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 82.4% vs previous month
Top companies in Pulmonology
3 companies that operate in the same segment as Belluscura (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Belluscura
Complete news archive for Belluscura
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Belluscura
Belluscura was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Belluscura is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Belluscura is a funded company, having raised a total of $6.38M across 8 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Jun 2016.
Provider of medical devices for laparoscopic procedures. It offers Passport a single-use, and disposable trocar (laparoscopic access device); Slyde- patient evacuation equipment ; Snap II - Level of Consciousness (LoC) device during general anesthesia, etc. The company aims to provide proprietary medical devices at affordable prices across a wide variety of treatment and diagnostic disciplines.
Belluscura's top competitors include ALung, Securisyn and Synapse Biomedical.
Belluscura offers X-PLOR, DISCOV-R, and Accessories.
Belluscura has made 2 acquisitions, including Nanotether, and TMT Acquisition.
Belluscura has 1 investor. Key investors include Tekcapital.
Belluscura operates through Belluscura, Llc.